Triall: Clinical trials are going digital

An Introduction to Triall

Clinical trials involve increasing amounts of data and electronic systems. This situation leads to a lack of oversight and uncertainty about the integrity and authenticity of the data collected, leading to a profound reduction in the efficiency and reliability of the development of new health products, such as drugs.

This results not only in the unreliability of drugs and vaccines (nowadays very common), but also makes them unaffordable, and brings problems of monitoring and data integrity that cause significant delays, costs and safety risks, as seen recently with the Covid-19 vaccines.

For this reason, I want to show you a new blockchain project called Triall (https://www.triall.io/), an ecosystem of industry-validated blockchain-integrated products to streamline clinical trials. Triall uses blockchain technology to protect clinical trial data and improve efficiency, trust and regulatory compliance for all parties involved and thus leave all these discussed problems behind.

https://medium.com/media/281386c8956062c1d243e0a3014fc0ed/href

What is Triall?

Triall (https://www.triall.io/) will be a blockchain-integrated software developed by clinical trial professionals that aims to launch a series of targeted clinical trial software applications. The platform works closely with the medical research industry to ensure that each of the “eClinical solutions” solves the real problems discussed. It is a series of new functionalities that respond to the increasing demands for data security and traceability from industry regulators around the world.

Triall, thanks to blockchain technology, will use Web 3.0 and integrate it into medical research, creating a digital ecosystem of blockchain-integrated software solutions to secure and streamline the development of new vaccines and therapies during clinical trials. With the blockchain infrastructure, Triall will obtain clinical trial data that is much more resistant to manipulation and will give interoperability and efficiency to many siloed systems and parties involved in clinical trial processes.

Goals

Triall’s main goal is to accelerate the introduction of safe and affordable vaccines and therapies into society by streamlining clinical trials by spreading awareness about the unique opportunities of blockchain technology for medical research and clinical trials.

To accomplish all this, they intend to make a platform aimed primarily at the community, offering an interaction service to share opinions and grow awareness of it. The first step is the launch of an Ambassador Program that rewards contributions, recognizing the value of quality third-party content.

Main core solutions

  • Verial eTMF: clinical document management application with blockchain proofing designed for data integrity and authenticity.
  • Triall CTMS: lightweight test management dashboard with blockchain API-based data integration.
  • Atena PRM: vendor selection and management platform with blockchain proof of bidding processes.

Tokenomics

The Triall ecosystem is a two-token system consisting of $TRL and T-CRED. On the one hand, $TRL is the main utility token and enables P2P clearing, governance and community engagement. On the other hand, T-CRED is the internal counterpart and is used to pay for Triall solutions and can only be created by converting $TRL.

The most important benefits of Triall tokens are that they provide access to ecosystem utilities, direct P2P compensation, provide community engagement, generate ecosystem governance and are based on the membership and reward system.

Token allocation

Staking program

Triall is launching a unique TRL participation program from which it has been allocated 8 million TRL tokens to reward users, with an APR of up to 250%. Anyone can participate if they have their tokens, but they must have previously signed up to the whitelist in order to participate.

Bounty program

The project gives the opportunity to earn TRL tokens performing some social media tasks and doing simple steps from the bounty program explained into the following Bounty0x here (Triall Bounties | Bounty0x), where you can access the link in order to see what are the conditions to become an early Triall contributor and start acquiring tokens.

For more information about the project, you can visit and read their Pitch Deck available here (https://www.triall.io/wp-content/uploads/2021/04/Triall-Whitepaper-v2.1.pdf). You can also stay tuned in their official Telegram Channel (https://t.me/triallcommunity). I hope you liked the post and soon I’ll send you new ones.

Partners

Conclusion

Triall is a unique project that aims to bring blockchain to the medical plus pharmaceutical and clinical trials side. To do so, they have put together a very competitive and combined team of professionals with 100+ clinical trials across 30+ countries. Besides, they have years of industry operations and potential customers, allowing to effectively bring the aforementioned solutions to market.

Social Media links

Website: https://www.triall.io/

Twitter: https://twitter.com/triallofficial

Telegram: https://t.me/triallcommunity

Whitepaper: https://www.triall.io/wp-content/uploads/2021/04/Triall-Whitepaper-v2.1.pdf

— — — — — — — — — — — — — — — — — — — — — — — — — — — — — —

Authorship

Email: adria.parcerisas.albes@gmail.com

Bounty0x username: adriaparcerisas

“A sponsored article written for a bounty reward.”


Triall: Clinical trials are going digital was originally published in DataDrivenInvestor on Medium, where people are continuing the conversation by highlighting and responding to this story.